These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 1468894

  • 1. Cefuroxime axetil vs. augmentin for the treatment of acute bronchitis and exacerbation of chronic obstructive pulmonary disease.
    Landau Z, Schlaffer F, Pitlik S.
    Isr J Med Sci; 1992 Nov; 28(11):797-9. PubMed ID: 1468894
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections.
    Brambilla C, Kastanakis S, Knight S, Cunningham K.
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):118-24. PubMed ID: 1396725
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections.
    Hebblethwaite EM, Brown GW, Cox DM.
    Drugs Exp Clin Res; 1987 Feb; 13(2):91-4. PubMed ID: 3582135
    [Abstract] [Full Text] [Related]

  • 8. Clinical comparison of cefuroxime axetil suspension and amoxicillin/clavulanate suspension in the treatment of pediatric patients with acute otitis media with effusion.
    Gooch WM, Blair E, Puopolo A, Paster Z, Schwartz RH, Miller HC, Smyre HL, Giguere GC, Collins JJ.
    Clin Ther; 1995 Feb; 17(5):838-51. PubMed ID: 8595636
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Augmentin in acute exacerbations of chronic bronchitis.
    Aigner K, Schindl R, Mittermayer H.
    J Int Med Res; 1984 Feb; 12(6):321-6. PubMed ID: 6335111
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis.
    Beghi G, Berni F, Carratù L, Casalini A, Consigli G, D'Antò M, Gioia V, Molino A, Paizis G, Vaghi A.
    J Chemother; 1995 Apr; 7(2):146-52. PubMed ID: 7666122
    [Abstract] [Full Text] [Related]

  • 14. Comparison of oral treatment of uncomplicated urogenital and rectal gonorrhoea with cefuroxime axetil ester or clavulanic acid potentiated amoxycillin (Augmentin).
    Schift R, van Ulsen J, Ansink-Schipper MC, van Joost T, Michel MF, Woudstra RK, Stolz E.
    Genitourin Med; 1986 Oct; 62(5):313-7. PubMed ID: 3533755
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis.
    Rademaker CM, Sips AP, Beumer HM, Hoepelman IM, Overbeek BP, Möllers MJ, Rozenberg-Arska M, Verhoef J.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():75-81. PubMed ID: 2286595
    [Abstract] [Full Text] [Related]

  • 17. Comparison of cefuroxime axetil, cefaclor, and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children.
    Pichichero M, Aronovitz GH, Gooch WM, McLinn SE, Maddern B, Johnson C, Darden PM.
    South Med J; 1990 Oct; 83(10):1174-7. PubMed ID: 2218657
    [Abstract] [Full Text] [Related]

  • 18. Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
    Pelletier LL.
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S238-43; discussion S244-5. PubMed ID: 1617044
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.